14 research outputs found

    Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

    Get PDF
    Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

    Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.

    Get PDF
    BACKGROUND AND PURPOSE: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. METHODS: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). RESULTS: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. CONCLUSIONS: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

    Structural studies of 2-methyl-7-substituted pyrazolo[1,5-a]pyrimidines

    No full text
    Six pyrazolo[1,5-a]pyrimidines bearing a 7-trifluoromethyl (three compounds), a 7-trichloromethyl (two compounds), and a 7-ethoxycarbonyl (one compound) have been structurally characterized. The new X-ray structures of 2-methyl-5-(p-bromophenyl)-7-trifluoromethylpyrazolo[1,5-a]pyrimidine (3) and 2-methyl-7-trichloromethylpyrazolo[1,5-a]pyrimidine (4) are reported. The combined use of GIAO/B3LYP/6-311++G(d,p) calculations with NMR spectroscopy in solution and in the solid state allows to establish some general rules that can be useful for characterizing related compounds. Compounds 3 and 4 present in the solid-state interesting intra- and intermolecular halogen bonds. © 2010 Hetero Corporation.Peer Reviewe

    Brønsted acid-base pairs of drugs as dual ionic liquids: NMR ionicity studies

    No full text
    Twenty-eight protic ionic liquids (PILs) have been prepared from Active Pharmaceutical Ingredients (APIs). They have been characterized by TGA, DSC and NMR. An important property of Ionic Liquids (ILs) such as the 'degree of ionicity' has been estimated from quantitative determinations by 1H NMR in DMSO-d6 solutions.Peer Reviewe

    The structure in the solid state and in solution of 3(5)-trifluoromethyl-4, 5(3)-polymethylenepyrazoles

    No full text
    The tautomerism of three polymethylenepyrazoles bearing at position 3(5) a trifluoromethyl group has been studied by NMR in solution (1H, 13C, 15N, 19F) and in the solid state ( 13C, 15N). The conclusion is that in all cases they are 3-CF3 tautomers. DFT calculations have been carried out to compare these compounds to the analogous 3-CH3 derivatives and to assess the Mills-Nixon effect in the case of trimethylene derivatives as well as the effect of replacing a CH3 by a CF3 group on the tautomerism.Peer Reviewe

    Transferring Atlantic maritime pine improved material to a region with marked Mediterranean influence in inland NW Spain. A likelihood-based approach on spatially adjusted field data

    Get PDF
    The inland region of Galicia (NW Spain) marks the boundary between the Atlantic climate of the coastal area and the typical Mediterranean climate of central Spain. Compared to the Atlantic coast, climate in this area has a pronounced summer drought, lower annual precipitation, and higher annual thermal oscillation. Despite the high productivity and ecological importance of maritime pine in inland Galicia, local forest reproductive material (FRM) of high genetic quality is not available for this area. Seed sources originating elsewhere and of unknown adaptation to this area are commonly used for reforestation. With the aim of finding new sources of FRM for this region and exploiting the genetic gains of existing breeding programmes, we analysed the performance in field conditions of improved families of the Coastal Galicia (CG) and Western Australia (WA) breeding programmes. Growth, stem characteristics and branch habit were evaluated in five progeny trials established following a coastal-to-inland gradient. Likelihood-based analyses were used to estimate genetic correlations between environments and to test statistically for causes and patterns of genotype x environment interaction. Because of the strong non-random spatial structures and heterogeneity of residual variances, the analyses were carried out using heterogeneous residual variance mixed models on spatially adjusted data. The results indicated that there is not sufficient evidence to subdivide Galicia into the two current deployment areas. Interaction patterns do not reveal significant differences between zones, and crossover interactions for height growth are present both between and within areas. On the inland sites, the Atlantic improved materials clearly outperformed unimproved seedlots tested in adjacent provenance trials, suggesting the feasibility of using both the CG and WA breeding materials as sources of FRM for reforestation in inland Galicia. Of the two, the WA material showed excellent results for all traits. The inclusion of this material into the Galician maritime pine breeding population should be strongly considered.This study was supported by the Instituto Nacional de Tecnologia Agraria y Alimentaria (INIA) projects RTA05-173 and RTA07-100.Peer reviewe
    corecore